BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28340873)

  • 1. Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Review of Current Disease Understanding and Therapeutic Approaches.
    Al-Zahrani M; Savage KJ
    Hematol Oncol Clin North Am; 2017 Apr; 31(2):189-207. PubMed ID: 28340873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.
    Heavican TB; Bouska A; Yu J; Lone W; Amador C; Gong Q; Zhang W; Li Y; Dave BJ; Nairismägi ML; Greiner TC; Vose J; Weisenburger DD; Lachel C; Wang C; Fu K; Stevens JM; Lim ST; Ong CK; Gascoyne RD; Missiaglia E; Lemonnier F; Haioun C; Hartmann S; Pedersen MB; Laginestra MA; Wilcox RA; Teh BT; Yoshida N; Ohshima K; Seto M; Rosenwald A; Ott G; Campo E; Rimsza LM; Jaffe ES; Braziel RM; d'Amore F; Inghirami G; Bertoni F; de Leval L; Gaulard P; Staudt LM; McKeithan TW; Pileri S; Chan WC; Iqbal J
    Blood; 2019 Apr; 133(15):1664-1676. PubMed ID: 30782609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified.
    Ludvigsen M; Bjerregård Pedersen M; Lystlund Lauridsen K; Svenstrup Poulsen T; Hamilton-Dutoit SJ; Besenbacher S; Bendix K; Møller MB; Nørgaard P; d'Amore F; Honoré B
    Blood Adv; 2018 Oct; 2(19):2533-2542. PubMed ID: 30291111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral T-Cell Lymphoma, not Otherwise Specified (PTCL-NOS).
    Oluwasanjo A; Kartan S; Johnson W; Alpdogan O; Gru A; Mishra A; Haverkos BM; Gong J; Porcu P
    Cancer Treat Res; 2019; 176():83-98. PubMed ID: 30596214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS)].
    Kinoshita T
    Nihon Rinsho; 2014 Mar; 72(3):512-8. PubMed ID: 24724412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral T-cell lymphoma--not otherwise specified.
    Savage KJ; Ferreri AJ; Zinzani PL; Pileri SA
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):321-9. PubMed ID: 20702104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral T-cell lymphoma - are we making progress?
    Khan N; Ozkaya N; Moskowitz A; Dogan A; Horwitz S
    Best Pract Res Clin Haematol; 2018 Sep; 31(3):306-314. PubMed ID: 30213401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.
    Coiffier B; Federico M; Caballero D; Dearden C; Morschhauser F; Jäger U; Trümper L; Zucca E; Gomes da Silva M; Pettengell R; Weidmann E; d'Amore F; Tilly H; Zinzani PL
    Cancer Treat Rev; 2014 Oct; 40(9):1080-8. PubMed ID: 25199959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How I treat the peripheral T-cell lymphomas.
    Moskowitz AJ; Lunning MA; Horwitz SM
    Blood; 2014 Apr; 123(17):2636-44. PubMed ID: 24615779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features.
    Wang T; Feldman AL; Wada DA; Lu Y; Polk A; Briski R; Ristow K; Habermann TM; Thomas D; Ziesmer SC; Wellik LE; Lanigan TM; Witzig TE; Pittelkow MR; Bailey NG; Hristov AC; Lim MS; Ansell SM; Wilcox RA
    Blood; 2014 May; 123(19):3007-15. PubMed ID: 24497534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
    Chihara D; Fanale MA; Miranda RN; Noorani M; Westin JR; Nastoupil LJ; Hagemeister FB; Fayad LE; Romaguera JE; Samaniego F; Turturro F; Lee HJ; Neelapu SS; Rodriguez MA; Wang M; Fowler NH; Davis RE; Medeiros LJ; Hosing C; Nieto YL; Oki Y
    Br J Haematol; 2017 Mar; 176(5):750-758. PubMed ID: 27983760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of high-dose therapy in peripheral T-cell lymphomas.
    Reimer P; Rüdiger T; Wilhelm M
    Clin Lymphoma Myeloma; 2006 Mar; 6(5):373-9. PubMed ID: 16640812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma.
    Iqbal J; Wright G; Wang C; Rosenwald A; Gascoyne RD; Weisenburger DD; Greiner TC; Smith L; Guo S; Wilcox RA; Teh BT; Lim ST; Tan SY; Rimsza LM; Jaffe ES; Campo E; Martinez A; Delabie J; Braziel RM; Cook JR; Tubbs RR; Ott G; Geissinger E; Gaulard P; Piccaluga PP; Pileri SA; Au WY; Nakamura S; Seto M; Berger F; de Leval L; Connors JM; Armitage J; Vose J; Chan WC; Staudt LM;
    Blood; 2014 May; 123(19):2915-23. PubMed ID: 24632715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
    Shustov A
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral T-cell lymphoma: a case-based discussion of recent advances in patient management.
    Franco CM; Popplewell LL; Horwitz SM
    Clin Adv Hematol Oncol; 2011 Apr; 9(4 Suppl 9):1-16. PubMed ID: 21559001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.
    Kawamoto K; Miyoshi H; Yanagida E; Yoshida N; Kiyasu J; Kozai Y; Morikita T; Kato T; Suzushima H; Tamura S; Muta T; Kato K; Eto T; Seki R; Nagafuji K; Sone H; Takizawa J; Seto M; Ohshima K
    Eur J Haematol; 2017 May; 98(5):459-466. PubMed ID: 28129454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Insights Into Pathogenesis of Peripheral T Cell Lymphoma: a Review.
    Lone W; Alkhiniji A; Manikkam Umakanthan J; Iqbal J
    Curr Hematol Malig Rep; 2018 Aug; 13(4):318-328. PubMed ID: 29951889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
    Gkotzamanidou M; Papadimitriou CA
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How I manage peripheral T-cell lymphoma, not otherwise specified and angioimmunoblastic T-cell lymphoma: current practice and a glimpse into the future.
    Schmitz N; de Leval L
    Br J Haematol; 2017 Mar; 176(6):851-866. PubMed ID: 27982416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.
    Agostinelli C; Piccaluga PP; Went P; Rossi M; Gazzola A; Righi S; Sista T; Campidelli C; Zinzani PL; Falini B; Pileri SA
    J Clin Pathol; 2008 Nov; 61(11):1160-7. PubMed ID: 18755717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.